Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

por Frias, Juan P., Bonora, Enzo, Nevarez Ruiz, Luis, Li, Ying G., Yu, Zhuoxin, Milicevic, Zvonko, Malik, Raleigh, Bethel, M. Angelyn, Cox, David A.
Publicado 2021

Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD‐11 trial

por Frias, Juan P., Bonora, Enzo, Nevárez Ruiz, Luis, Hsia, Stanley H., Jung, Heike, Raha, Sohini, Cox, David A., Bethel, M. Angelyn, Konig, Manige
Publicado 2021